SYNBIOTICS CORP
S-8, 1997-04-18
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: CONSECO INC ET AL, S-4/A, 1997-04-18
Next: SYNBIOTICS CORP, POS AM, 1997-04-18



<PAGE>
 
     AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 18, 1997
                                                      REGISTRATION NO. 333-_____
================================================================================
                    U.S. SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                                  ----------

                                    FORM S-8
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933

                             SYNBIOTICS CORPORATION
                (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

             CALIFORNIA                                   95-3737816
   (State or other jurisdiction of                     (I.R.S. Employer
   incorporation or organization)                     Identification No.)

          11011 VIA FRONTERA
         SAN DIEGO, CALIFORNIA                              92127
(Address of principal executive offices)                  (Zip Code)


                             SYNBIOTICS CORPORATION
                             1996 STOCK OPTION PLAN
                            (Full title of the plan)

                                KENNETH M. COHEN
                     PRESIDENT AND CHIEF EXECUTIVE OFFICER
                             SYNBIOTICS CORPORATION
                11011 VIA FRONTERA, SAN DIEGO, CALIFORNIA  92127
                    (Name and address of agent for service)

                                 (619) 451-3771
         (Telephone number, including area code, of agent for service)

                                   Copies to:
                            HAYDEN J. TRUBITT, ESQ.
                          BROBECK, PHLEGER & HARRISON
                         550 West C Street, Suite 1300
                          San Diego, California  92101

                                  ----------

      This Registration Statement shall become effective immediately upon
      filing with the Securities and Exchange Commission, and sales of the
      registered securities will begin as soon as reasonably practicable
      after such effective date.

                                  ----------

                        CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------------------------

 TITLE OF SECURITIES TO BE       AMOUNT TO BE           PROPOSED MAXIMUM              PROPOSED MAXIMUM                 AMOUNT OF
        REGISTERED                REGISTERED         OFFERING PRICE PER SHARE      AGGREGATE OFFERING PRICE         REGISTRATION FEE
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                              <C>                 <C>                           <C>                               <C>
Common Stock (under
 1995 Stock Option Plan)          250,000/1/                 $3.50/2/                   $875,000                     $265.15
</TABLE>

(1)  This Registration Statement shall also cover any additional shares of
Common Stock which become issuable under the 1995 Stock Option Plan by reason of
any stock dividend, stock split, recapitalization or other similar transaction
effected without the receipt of consideration which results in an increase in
the number of the Company's outstanding shares of Common Stock.
(2)  Calculated solely for the purposes of this offering under Rule 457(h) of
the Securities Act of 1933, as amended, on the basis of the last sale reported
per share of Common Stock of Synbiotics Corporation on April 15, 1997 as
reported on the Nasdaq National Market.

================================================================================
<PAGE>
 
                                    PART II
                                    -------

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
               --------------------------------------------------

ITEM 3.   INCORPORATION OF DOCUMENTS BY REFERENCE
          ---------------------------------------

Synbiotics Corporation (the "Company") hereby incorporates by reference into
this Registration Statement the following documents previously filed with the
Securities and Exchange Commission (the "Commission"):

     (a)  the Company's latest Annual Report, filed on Form 10-KSB for the year
          ended December 31, 1996; and

     (b)  the description of the Company's Common Stock in the Company's
          Registration Statement on Form S-4, Registration No. 222-10343.

All documents filed by the Company pursuant to Section 13(a), 13(c), 14 or 15(d)
of the Securities Exchange Act of 1934 after the date of this Registration
Statement and prior to the filing of a post-effective amendment which indicates
that all securities offered hereby have been sold or which deregisters all
securities then remaining unsold, shall be deemed to be incorporated by
reference into this Registration Statement and to be a part hereof from the date
of filing of such documents.

A copy of any of the above documents will be furnished to each participant in
the 1996 Stock Option Plan, without charge, upon written or oral request to the
Corporate Secretary, Synbiotics Corporation, 11011 Via Frontera, San Diego,
California  92127, or upon telephoning the Company at (619) 451-3771.


ITEM 4.   DESCRIPTION OF SECURITIES
          -------------------------

Not applicable.


ITEM 5.   INTERESTS OF NAMED EXPERTS AND COUNSEL
          --------------------------------------

Not applicable.


ITEM 6.   INDEMNIFICATION OF DIRECTORS AND OFFICERS
          -----------------------------------------

     (a)  Section 317 of the California General Corporation Law provides for the
          indemnification of officers and directors of the Company against
          expenses, judgments, fines and amounts paid in settlement under
          certain conditions and subject to certain limitations.

     (b)  Article VIII, Section 4 of the Bylaws of the Company provides that the
          Company shall have the power to indemnify any person who is or was a
          director, officer, employee or agent of the Company or any person who
          is or was serving at the request of the Company as a director,
          officer, employee or agent of another corporation, subject to certain
          limitations.  The rights to indemnity thereunder continue as to a
          person who has ceased to be director, officer, employee or agent and
          shall inure to the benefit of the heirs, executors and administrators
          of the person.  In addition,

                                     II-1
<PAGE>
 
          expenses incurred by a director, officer, employee or agent in
          defending a civil or criminal action, suit or proceeding by reason of
          the fact that he or she is or was a director, officer, employee or
          agent of the Company (or was serving at the Company's request as a
          director, officer, employee or agent of another corporation) may be
          paid by the Company in advance of the final disposition of such
          action, suit or proceeding upon receipt of an undertaking by or on
          behalf of such director or officer to repay such amount if it shall
          ultimately be determined that he or she is not entitled to be
          indemnified by the Company.

     (c)  Article Seventh of the Company's Restated Articles of Incorporation
          provides that liability of the directors of the Company for monetary
          damages shall be eliminated to the fullest extent permissible under
          California law.  Article Eighth of the Company's Articles of
          Incorporation further provides that the Company is authorized to
          indemnify agents (as defined in Section 317 of the California General
          Corporation Law) in excess of the indemnification otherwise permitted
          by Section 317, subject to the limits set forth in Section 204 of the
          California General Corporation Law.

     (d)  Pursuant to authorization provided under the Articles of
          Incorporation, the Company has entered into indemnification agreements
          with its directors and officers.  Generally, the indemnification
          agreements attempt to provide the maximum protection permitted by
          California law as it may be amended from time to time.  Moreover, the
          indemnification agreements provide for certain additional
          indemnification.  The indemnification agreements provide for the
          Company to advance to the individual any and all reasonable expenses
          (including legal fees and expenses) incurred in investigating or
          defending an action, suit or proceeding.  In order to receive an
          advance of expenses, the individual must undertake to repay such
          advance upon a determination that he or she is not entitled to
          indemnification.  The Company's Bylaws contain a provision of similar
          effect relating to advancement of expenses to a director or officer,
          subject to an undertaking to repay if it is ultimately determined that
          indemnification is unavailable.


ITEM 7.   EXEMPTION FROM REGISTRATION CLAIMED
          -----------------------------------

Not applicable.


ITEM 8.   EXHIBITS
          --------

<TABLE> 
<CAPTION> 
Exhibit No.  Exhibit
- -----------  -------
<S>          <C> 
 5.1         Opinion and consent of Brobeck, Phleger & Harrison.
23.1         Consent of Brobeck, Phleger & Harrison is contained in Exhibit 5 to
              this Registration Statement on Form S-8.
23.2         Consent of Price Waterhouse LLP, independent accountants.
24.1         Power of Attorney, reference is made to page II-3 of this
              Registration Statement on Form S-8.
99.1         1996 Stock Option Plan.
99.2         Form of Notice of Grant of Stock Option.
</TABLE> 

                                     II-2
<PAGE>
 
ITEM 9.   UNDERTAKINGS
          ------------

1.   The undersigned Registrant hereby undertakes:

     (a)  To file, during any period in which it offers or sells securities, a
          post-effective amendment to this Registration Statement to include any
          additional or changed material information on the plan of
          distribution;

     (b)  That, for purposes of determining any liability under the Securities
          Act of 1933, each such post-effective amendment shall be treated as a
          new Registration Statement of the securities offered therein, and the
          offering of such securities at that time shall be treated as the
          initial bona fide offering thereof; and

     (c)  To remove from registration by means of a post-effective amendment any
          of the securities that remain unsold at the end of the offering.


                                   SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8, and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of San Diego, State of California, on this 18th day of
April, 1997.

                         SYNBIOTICS CORPORATION

                         By   /s/ Kenneth M. Cohen
                              -------------------------------------
                              Kenneth M. Cohen
                              President and Chief Executive Officer


                               POWER OF ATTORNEY


KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned officers and directors
of Synbiotics Corporation, a California corporation, do hereby constitute and
appoint Kenneth M. Cohen and Michael K. Green, or either of them, as his true
and lawful attorneys-in-fact and agents with full power of substitution and
resubstitution, for him and in his name, place and stead, in any and all
capacities, to sign any and all amendments (including post-effective amendments)
to this Registration Statement and any Registration Statement related to this
Registration Statement and filed pursuant to Rule 462 under the Securities Act
of 1933, as amended, and to file the same, with all exhibits thereto, and other
documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, full power and authority to do
and perform each and every act and thing requisite and necessary to be done in
connection therewith as fully to all intents and purposes as he might or could
do in person, hereby ratifying and confirming all that said attorneys-in-fact
and agents, or their substitute or substitutes may lawfully do or cause to be
done by virtue hereof.

                                     II-3
<PAGE>
 
Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed by the following persons in the capacities and on the
dates indicated.
<TABLE>
<CAPTION>
 
 
Signature                                         Title                              Date
- -------------------------   -------------------------------------------------   --------------
<S>                         <C>                                                 <C>
 
/s/ Kenneth M. Cohen        Chief Executive Officer, President and Director     April 18, 1997
- -------------------------   (Principal Executive Officer)
Kenneth M. Cohen   

/s/ Michael K. Green        Chief Financial Officer Vice President - Finance    April 18, 1997
- -------------------------   (Principal Financial Officer)
Michael K. Green  

/s/ Keith A. Butler         Chief Accounting Officer and Corporate Controller   April 18, 1997
- -------------------------   (Principal Accounting Officer)
Keith A. Butler  

/s/ Patrick Owen Burns      Director                                            April 18, 1997
- -------------------------
Patrick Owen Burns
 
/s/ James C. DeCesare       Director                                            April 18, 1997
- -------------------------
James C. DeCesare
 
/s/ Brenda D. Gavin         Director                                            April 18, 1997
- -------------------------
Brenda D. Gavin
 
/s/ M. Blake Ingle          Director                                            April 18, 1997
- -------------------------
M. Blake Ingle
 
/s/ Donald E. Phillips      Director                                            April 18, 1997
- -------------------------
Donald E.  Phillips
</TABLE>

                                     II-4
<PAGE>
 
                       SECURITIES AND EXCHANGE COMMISSION

                                WASHINGTON, D.C.


                                    EXHIBITS

                                       TO

                                    FORM S-8

                                     UNDER

                             SECURITIES ACT OF 1933


                            SYNBIOTICS CORPORATION
<PAGE>
 
                                 EXHIBIT INDEX
<TABLE> 
<CAPTION> 
Exhibit No.       Exhibit
- -----------       -------
<S>               <C>  
 5.1              Opinion and consent of Brobeck, Phleger & Harrison.
23.1              Consent of Brobeck, Phleger & Harrison is contained in Exhibit
                   5 to this Registration Statement on Form S-8.
23.2              Consent of Price Waterhouse LLP, independent accountants.
24.1              Power of Attorney, reference is made to page II-3 of this
                   Registration Statement on Form S-8.
99.1              1996 Stock Option Plan.
99.2              Form of Notice of Grant of Stock Option.
</TABLE> 

<PAGE>
 
                                                                     EXHIBIT 5.1
                                                                     -----------


               OPINION AND CONSENT OF BROBECK, PHLEGER & HARRISON
               --------------------------------------------------


Synbiotics Corporation
11011 Via Frontera
San Diego, CA  92127

Re:  Synbiotics Corporation Registration Statement on Form S-8 for 250,000
     ---------------------------------------------------------------------
     Shares of Common Stock
     ----------------------

Ladies and Gentlemen:

In connection with your registration on Form S-8 (the "Registration Statement")
under the Securities Act of 1933, as amended, of 250,000 shares of Common Stock
of Synbiotics Corporation (the "Company") under the 1996 Stock Option Plan, we
advise you that, in our opinion, if and when such shares have been issued and
sold (and the consideration therefor received) pursuant to the provisions of the
option agreements issued under the 1996 Stock Option Plan and in accordance with
the Registration Statement, such shares will be duly-authorized, validly-issued,
fully-paid and non-assessable share of the Company's Common Stock.

We hereby consent to the filing of this opinion as an exhibit to the
Registration Statement.

Very truly yours,


BROBECK, PHLEGER & HARRISON

San Diego, California
April 18, 1997

                                      -1-

<PAGE>
 
                                                                    EXHIBIT 23.2
                                                                    ------------

                       CONSENT OF INDEPENDENT ACCOUNTANTS
                       ----------------------------------


We hereby consent to the incorporation by reference in this Registration
Statement on Form S-8 of our report dated February 21, 1997 appearing on page 15
of Synbiotics Corporation's Annual Report on Form 10-KSB for the year ended
December 31, 1996.



PRICE WATERHOUSE LLP

San Diego, California
April 18,  1997

                                      -1-

<PAGE>
 
                                                                    EXHIBIT 24.1
                                                                    ------------


                               POWER OF ATTORNEY
                               -----------------

  Reference is made to page II-3 of this Registration Statement on Form S-8.

                                      -1-

<PAGE>
 
                                                                    EXHIBIT 99.1
                                                                    ------------

                             SYNBIOTICS CORPORATION
                             1996 STOCK OPTION PLAN
                             ----------------------

                                  ARTICLE ONE
                               GENERAL PROVISIONS
                               ------------------

I.   GIST OF THE PLAN; ELIGIBILITY

Under this 1996 Stock Option Plan (the "Plan"), the persons eligible to be
granted non-qualified options to purchase shares of common stock of the
Corporation are as follows:

     A.   employees of the Corporation (or any Parent or Subsidiary), other than
          directors or officers of the Corporation, who render services which
          contribute to the management, growth and financial success of the
          Corporation (or any Parent or Subsidiary);

     B.   directors or officers of the Corporation not previously employed by or
          serving as a director of the Corporation before the grant of the
          option and for whom the grant is an inducement essential to the
          individual's entering into a service relationship with the
          Corporation; and

     C.   those consultants or other independent contractors, other than
          directors of the Corporation, who provide valuable services to the
          Corporation (or any Parent or Subsidiary).

No one person participating in the Plan may receive options for more than
200,000 shares of Common Stock in the aggregate over the term of the Plan.

II.  ADMINISTRATION OF THE PLAN

     A.   This Plan shall be administered by the Board (the "Plan
          Administrator").

     B.   The Plan Administrator shall have full power and authority (subject to
          the express provisions of the Plan) to establish such rules and
          regulations as it may deem appropriate for the proper administration
          of the Plan and to make such determinations under, and issue such
          interpretations of, the Plan and any outstanding option grants as it
          may deem necessary or advisable.  Decisions of the Plan Administrator
          shall be final and binding on all parties who have an interest in the
          Plan or any outstanding option.

III. STOCK SUBJECT TO THE PLAN

     A.   The stock issuable under the Plan shall be shares of authorized but
          unissued common stock of the Corporation ("Common Stock").  The
          maximum number of shares of Common Stock which may be issued over the
          term of the Plan shall not exceed 250,000 shares.

     B.   Shares of Common Stock subject to outstanding options shall be
          available for subsequent issuance under the Plan to the extent (i) the
          options expire or terminate for any reason prior to exercise in full
          or (ii) the options are cancelled in accordance with the cancellation-
          regrant provisions of Article Two.  All shares issued under the Plan,
          whether or not those shares are subsequently

                                      -1-
<PAGE>
 
          repurchased by the Corporation, shall reduce on a share-for-share
          basis the number of shares of Common Stock available for subsequent
          issuance under the Plan.  In addition, should the exercise price of an
          option under the Plan be paid with shares of Common Stock or should
          shares of Common Stock otherwise issuable under the Plan be withheld
          by the Corporation in satisfaction of the withholding taxes incurred
          in connection with the exercise of an option under the Plan, then the
          number of shares of Common Stock available for issuance under the Plan
          shall be reduced by the gross number of shares for which the option is
          exercised, and not by the net number of shares of Common Stock issued
          to the holder of such option.

     C.   Should any change be made to the Common Stock by reason of any stock
          split, stock dividend, recapitalization, combination of shares,
          exchange of shares or other change affecting the outstanding Common
          Stock as a class without the Corporation's receipt of consideration,
          appropriate adjustments shall be made to (i) the maximum number and/or
          class of securities issuable under the Plan, (ii) the number and/or
          class of securities for which any one person may be granted options
          over the term of the Plan, and (iii) the number and/or class of
          securities and the exercise price per share in effect under each
          outstanding option  in order to prevent the dilution or enlargement of
          benefits thereunder.  The adjustments determined by the Plan
          Administrator shall be final, binding and conclusive.

IV.  SHAREHOLDER RIGHTS

The holder of an option ("Optionee") shall have no shareholder rights with
respect to the shares subject to the option until such person shall have
exercised the option, paid the exercise price and become a holder of record of
the purchased shares.


                                  ARTICLE TWO

I.   OPTION TERMS

Each option shall be a non-qualified stock option and shall be evidenced by one
or more documents in the form approved by the Plan Administrator; provided,
                                                                  -------- 
however, that each such document shall comply with the terms specified below.

     A.   Exercise Price.
          -------------- 

          1.   The exercise price per share shall be fixed by the Plan
               Administrator.

          2.   The exercise price shall become immediately due upon exercise of
               the option and shall, subject to the documents evidencing the
               option, be payable in one or more of the forms specified below:

               (i)    cash or check made payable to the Corporation,

               (ii)   shares of Common Stock held for the requisite period
                      necessary to avoid a charge to the Corporation's earnings
                      for financial reporting purposes and valued at Fair Market
                      Value on the exercise date,

               (iii)  as may be permitted by Section I of Article Three, or

                                      -2-
<PAGE>
 
               (iv) through a special sale and remittance procedure pursuant to
                    which the Optionee shall concurrently provide irrevocable
                    written instructions to (a) a Corporation-designated
                    brokerage firm to effect the immediate sale of the purchased
                    shares and remit to the Corporation, out of the sale
                    proceeds available on the settlement date, sufficient funds
                    to cover the aggregate exercise price payable for the
                    purchased shares plus all applicable Federal, state and
                    local income and employment taxes required to be withheld by
                    the Corporation by reason of such exercise and (b) the
                    Corporation to deliver the certificates for the purchased
                    shares directly to such brokerage firm in order to complete
                    the sale transaction.

     Except to the extent such sale and remittance procedure is utilized,
     payment of the exercise price for the purchased shares must be made on the
     exercise date.

     B.   Exercise and Term of Options.  Each option shall be exercisable at
          ----------------------------                                      
          such time or times, during such period and for such number of shares
          as shall be determined by the Plan Administrator and set forth in the
          documents evidencing the option.

     C.   Effect of Termination of Service.
          -------------------------------- 

          The Plan Administrator shall have the discretion, exercisable either
          at the time an option is granted or at any time while the option
          remains outstanding, to:

          1.   extend the period of time for which the option is to remain
               exercisable following the Optionee's cessation of Service from
               the period otherwise in effect for that option to such greater
               period of time as the Plan Administrator shall deem appropriate,
               and/or

          2.   permit the option to be exercised, during any applicable post-
               Service exercise period, not only with respect to the number of
               vested shares of Common Stock for which such option is
               exercisable at the time of the Optionee's cessation of Service
               but also with respect to one or more additional installments in
               which the Optionee would have vested under the option had the
               Optionee continued in Service.

     D.   Repurchase Rights.  The Plan Administrator shall have the discretion
          -----------------                                                   
          to grant options subject to the exercise condition that the Optionee
          enter into a contract giving the Corporation the right to repurchase
          the shares.  The terms upon which such repurchase right shall be
          exercisable (including the period and procedure for exercise and the
          appropriate vesting schedule for the purchased shares) shall be
          established by the Plan Administrator and set forth in the document
          evidencing such repurchase right.

II.  ACCELERATION; CORPORATE TRANSACTION

     A.   The Plan Administrator shall have the discretion, exercisable either
          at the time an option is granted under the Plan, or at any time while
          the option or stock remains outstanding, to provide for the
          acceleration of one or more outstanding options and the termination of
          repurchase rights on one or more outstanding shares upon the
          occurrence of such events as the Plan Administrator may determine,
          including upon a Corporate Transaction regardless or whether or not
          such options are to be assumed or replaced or the repurchase rights
          are to be assigned in the Corporate Transaction.

                                      -3-
<PAGE>
 
     B.   Notwithstanding Paragraph A, in the event of any Corporate
          Transaction, each outstanding option shall automatically accelerate so
          that each such option shall, immediately prior to the effective date
          of the Corporate Transaction, become fully exercisable for all of the
          shares of Common Stock at the time subject to such option and may be
          exercised for any or all of those shares as fully-vested shares of
          Common Stock.  However, an outstanding option shall not so accelerate
          if and to the extent:  (i) such option is, in connection with the
          Corporate Transaction, either to be assumed by the successor
          corporation (or parent thereof) or to be replaced with a comparable
          option to purchase shares of the capital stock of the successor
          corporation (or parent thereof), (ii) such option is to be replaced
          with a cash incentive program of the successor corporation which
          preserves the spread existing on the unvested option shares at the
          time of the Corporate Transaction and provides for subsequent payout
          in accordance with the same vesting schedule applicable to such option
          or (iii) the acceleration of such option is subject to other
          limitations imposed by the Plan Administrator at the time of the
          option grant.  The determination of option comparability under clause
          (i) above shall be made by the Plan Administrator, and its
          determination shall be final, binding and conclusive.

     C.   All outstanding repurchase rights shall also terminate automatically,
          and the shares of Common Stock subject to those terminated rights
          shall immediately vest in full, in the event of any Corporate
          Transaction, except to the extent: (i) those repurchase rights are to
          be assigned to the successor corporation (or parent thereof) in
          connection with such Corporate Transaction or (ii) such accelerated
          vesting is precluded by other limitations imposed by the Plan
          Administrator at the time the repurchase right is issued.

     D.   Immediately following the consummation of the Corporate Transaction,
          all outstanding options shall terminate and cease to be outstanding,
          except to the extent assumed by the successor corporation (or parent
          thereof).

     E.   Each option which is assumed in connection with a Corporate
          Transaction shall be appropriately adjusted, immediately after such
          Corporate Transaction, to apply to the number and class of securities
          which would have been issuable to the Optionee in consummation of such
          Corporate Transaction had the option been exercised immediately prior
          to such Corporate Transaction.  Appropriate adjustments shall also be
          made to (i) the number and class of securities available for issuance
          under the Plan on both an aggregate and per Optionee basis following
          the consummation of such Corporate Transaction and (ii) the exercise
          price payable per share under each outstanding option, provided the
                                                                 --------    
          aggregate exercise price payable for such securities shall remain the
          same.

     F.   Any options which are assumed or replaced in the Corporate Transaction
          and do not otherwise accelerate at that time, shall automatically
          accelerate (and any of the Corporation's outstanding repurchase rights
          which do not otherwise terminate at the time of the Corporate
          Transaction) shall automatically terminate and the shares of Common
          Stock subject to those terminated rights shall immediately vest in
          full in the event the Optionee's Service should subsequently terminate
          by reason of an Involuntary Termination within eighteen (18) months
          following the effective date of such Corporate Transaction.  Any
          options so accelerated shall remain exercisable for fully-vested
          shares until the earlier of (i) the expiration of the option term or
                           -------                                            
          (ii) the expiration of the one (1)-year period measured from the
          effective date of the Involuntary Termination.

     G.   The grant of options under the Plan shall in no way affect the right
          of the Corporation to adjust, reclassify, reorganize or otherwise
          change its capital or business structure or to merge, consolidate,
          dissolve, liquidate or sell or transfer all or any part of its
          business or assets.

                                      -4-
<PAGE>
 
III. CANCELLATION AND REGRANT OF OPTIONS

The Plan Administrator shall have the authority to effect, at any time and from
time to time, with the consent of the affected option holders, the cancellation
of any or all outstanding options under the Plan and to grant in substitution
new options covering the same or different number of shares of Common Stock but
with a different exercise price per share.


                                 ARTICLE THREE
                                 MISCELLANEOUS
                                 -------------

I.   FINANCING

     A.   The Plan Administrator may permit any Optionee to pay the option
          exercise price by delivering a promissory note payable in one or more
          installments.   The terms of any such promissory note (including the
          interest rate and the terms of repayment) shall be established by the
          Plan Administrator in its sole discretion.  Promissory notes may be
          authorized with or without security or collateral.  In all events, the
          maximum credit available to the Optionee may not exceed the sum of (i)
          the aggregate option exercise price plus (ii) any Federal, state and
          local income and employment tax liability incurred by the Optionee in
          connection with the option exercise.

     B.   The Plan Administrator may, in its discretion, determine that one or
          more such promissory notes shall be subject to forgiveness by the
          Corporation in whole or in part upon such terms as the Plan
          Administrator may deem appropriate.

II.  TAX WITHHOLDING

     A.   The Corporation's obligation to deliver shares of Common Stock upon
          the exercise of options under the Plan shall be subject to the
          satisfaction of all applicable Federal, state and local income and
          employment tax withholding requirements.

     B.   The Plan Administrator may, in its discretion, provide any or all
          Optionees with the right to use shares of Common Stock in satisfaction
          of all or part of the federal, state and local income or employment
          taxes incurred by such holders in connection with the exercise of
          their options.  Such right may be provided to any such holder in
          either or both of the following formats:

          1.   Stock Withholding:  The election to have the Corporation
               -----------------                                       
               withhold, from the shares of Common Stock otherwise issuable upon
               the exercise of such option, a portion of those shares with an
               aggregate Fair Market Value equal to the percentage of such taxes
               (not to exceed one hundred percent (100%)) designated by the
               holder.

          2.   Stock Delivery:  The election to deliver to the Corporation, at
               --------------                                                 
               the time the option is exercised, one or more shares of Common
               Stock previously acquired by such holder (other than in
               connection with the option exercise triggering the taxes) with an
               aggregate Fair Market Value equal to the percentage of such taxes
               (not to exceed one hundred percent (100%)) designated by the
               holder.

III. EFFECTIVE DATE AND TERM OF THE PLAN

     A.   The Plan shall become effective on the date the Plan is adopted by the
          Board, and options may be granted from and after the effective date.

                                      -5-
<PAGE>
 
     B.  The Plan shall terminate upon the earliest of (i) April 27, 2006, (ii)
                                           --------                            
the date on which all shares available for issuance under the Plan shall have
been issued pursuant to the exercise of the options or (iii) the termination of
all outstanding options in connection with a Corporate Transaction.  Upon such
Plan termination, all options outstanding on such date shall thereafter continue
to have force and effect in accordance with the provisions of the documents
evidencing such options.

IV.  AMENDMENT OF THE PLAN

The Board shall have complete and exclusive power and authority to amend or
modify the Plan in any or all respects.  However, no such amendment or
modification shall adversely affect the rights and obligations with respect to
options at the time outstanding under the Plan unless the Optionee consents to
such amendment or modification.

V.   USE OF PROCEEDS

Any cash proceeds received by the Corporation from the sale of shares of Common
Stock under the Plan shall be used for general corporate purposes.

VI.  REGULATORY APPROVALS

     A.   The implementation of the Plan, the granting of any option under the
          Plan and the issuance of any shares of Common Stock upon the exercise
          of any option shall be subject to the Corporation's procurement of all
          approvals and permits required by regulatory authorities having
          jurisdiction over the Plan, the options granted under it and the
          shares of Common Stock issued pursuant to it.

     B.   No shares of Common Stock or other assets shall be issued or delivered
          under the Plan unless and until there shall have been compliance with
          all applicable requirements of Federal and state securities laws,
          including the filing and effectiveness of the Form S-8 registration
          statement for the shares of Common Stock issuable under the Plan, and
          all applicable listing requirements of any stock exchange (or the
          Nasdaq National Market, if applicable) on which Common Stock is then
          listed for trading.

VII. NO EMPLOYMENT/SERVICE RIGHTS

Nothing in the Plan shall confer upon the Optionee any right to continue in
Service for any period of specific duration or interfere with or otherwise
restrict in any way the rights of the Corporation (or any Parent or Subsidiary
employing or retaining such person) or of the Optionee, which rights are hereby
expressly reserved by each, to terminate such person's Service at any time for
any reason, with or without cause.

VIII.  DEFINITIONS

Capitalized terms not otherwise defined in this Plan shall have the meanings
assigned to such terms in the attached Appendix.

                                      -6-
<PAGE>
 
                                    APPENDIX
                                    --------


The following definitions shall be in effect under the Plan:

     A.   BOARD shall mean the Corporation's Board of Directors.
          -----                                                 

     B.   CORPORATE TRANSACTION shall mean any of the following shareholder-
          ---------------------                                            
          approved transactions to which the Corporation is a party:

          1.   a merger or consolidation in which the Corporation is not the
               surviving entity, except for a transaction the principal purpose
               of which is to change the State of the Corporation's
               incorporation,

          2.   the sale, transfer or other disposition of all or substantially
               all of the assets of the Corporation in liquidation or
               dissolution of the Corporation, or

          3.   any reverse merger in which the Corporation is the surviving
               entity but in which securities possessing more than fifty percent
               (50%) of the total combined voting power of the Corporation's
               outstanding securities are transferred to holders different from
               those who held such securities immediately prior to such merger.

     C.   CORPORATION shall mean Synbiotics Corporation, a California
          -----------                                                
          corporation.

     D.   FAIR MARKET VALUE per share of Common Stock on any relevant date shall
          -----------------                                                     
          be determined in accordance with the following provisions:

          1.   If the Common Stock is at the time traded on the Nasdaq National
               Market, then the Fair Market Value shall be the closing selling
               price per share of Common Stock on the date in question, as such
               price is reported by the National Association of Securities
               Dealers on the Nasdaq National Market or any successor system.
               If there is no closing selling price for the Common Stock on the
               date in question, then the Fair Market Value shall be the closing
               selling price on the last preceding date for which such quotation
               exists.

          2.   If the Common Stock is at the time listed on any stock exchange,
               then the Fair Market Value shall be the closing selling price per
               share of Common Stock on the date in question on the stock
               exchange determined by the Plan Administrator to be the primary
               market for the Common Stock, as such price is officially quoted
               in the composite tape of transactions on such exchange.  If there
               is no closing selling price for the Common Stock on the date in
               question, then the Fair Market Value shall be the closing selling
               price  on the last preceding date for which such quotation
               exists.

     E.   INVOLUNTARY TERMINATION shall mean the termination of the Service of
          -----------------------                                             
          any individual which occurs by reason of:

          1.   such individual's involuntary dismissal or discharge by the
               Corporation for reasons other than Misconduct, or

                                      A-1
<PAGE>
 
          2.   such individual's voluntary resignation following (A) a change in
               his or her position with the Corporation which materially reduces
               his or her level of responsibility, (B) a reduction in his or her
               level of compensation (including base salary, fringe benefits and
               any non-discretionary and objective-standard incentive payment or
               bonus award) by more than fifteen percent (15%) or (C) a
               relocation of such individual's place of employment by more than
               fifty (50) miles, provided and only if such change, reduction or
               relocation is effected by the Corporation without the
               individual's consent.
 
     F.   MISCONDUCT shall mean the commission of any act of fraud, embezzlement
          ----------                                                            
          or dishonesty by the Optionee, any unauthorized use or disclosure by
          such person of confidential information or trade secrets of the
          Corporation (or any Parent or Subsidiary), or any other intentional
          misconduct by such person adversely affecting the business or affairs
          of the Corporation (or any Parent or Subsidiary) in a material manner.
          The foregoing definition shall not be deemed to be inclusive of all
          the acts or omissions which the Corporation (or any Parent or
          Subsidiary) may consider as grounds for the dismissal or discharge of
          any Optionee or other person in the Service of the Corporation (or any
          Parent or Subsidiary).

     G.   PARENT shall mean any corporation (other than the Corporation) in an
          ------                                                              
          unbroken chain of corporations ending with the Corporation, provided
          each corporation in the unbroken chain (other than the Corporation)
          owns, at the time of the determination, stock possessing fifty percent
          (50%) or more of the total combined voting power of all classes of
          stock in one of the other corporations in such chain.

     H.   SERVICE shall mean the provision of services to the Corporation or any
          -------                                                               
          Parent or Subsidiary by an individual in the capacity of an employee,
          a non-employee member of the Board or a consultant or independent
          contractor.

     I.   SUBSIDIARY shall mean each corporation (other than the Corporation) in
          ----------                                                            
          an unbroken chain of corporations beginning with the Corporation,
          provided each such corporation (other than the last corporation) in
          the unbroken chain owns, at the time of the determination, stock
          possessing fifty percent (50%) or more of the total combined voting
          power of all classes of stock in one of the other corporations in such
          chain.

                                      A-2

<PAGE>
 
                                                                    EXHIBIT 99.2
                                                                    ------------


                             SYNBIOTICS CORPORATION
                        NOTICE OF GRANT OF STOCK OPTION
                        -------------------------------

Notice is hereby given of the following non-qualified stock option grant (the
"Option") to purchase shares of the Common Stock of Synbiotics Corporation (the
"Corporation") in accordance with the Corporation's 1996 Stock Option Plan (the
"Plan"):

Optionee:
- -------- ------------------------------------------------------------

Grant Date:
- ---------- ------------------------------------------------------

Option Price:  $           per share
- ------------    ----------                    

Number of Option Shares:             shares
- -----------------------  -----------                  

Vesting Commencement Date:
- ------------------------- ----------------------------------------

Expiration Date:
- --------------- -----------------------------------------------------

Exercise Schedule:
- ----------------- 

This Option may be exercised, at any time before it terminates or expires, for
all or any portion of the vested Option Shares.

The Option Shares shall vest in a series of successive equal quarterly
installments over sixteen (16) quarters of Service completed by the Optionee
commencing with the Vesting Commencement Date.

Other Special Provisions:
- ------------------------ 

None.

Optionee agrees to be bound by the terms and conditions of the Option as set
forth in the Stock Option Agreement attached hereto as Exhibit "A".

Optionee also understands that the Option is granted subject to and in
accordance with the express terms and conditions of the Plan, a copy of which is
attached hereto as Exhibit "B", and agrees to be bound by the terms and
conditions of the Plan.

Optionee hereby acknowledges receipt of a copy of the official Plan prospectus.

                                      -1-
<PAGE>
 
NO EMPLOYMENT OR SERVICE CONTRACT.  Nothing in the Stock Option Agreement or the
- ---------------------------------                                               
Plan shall confer upon the Optionee the right to continue in the Service of the
Corporation for any period of specific duration or interfere with or otherwise
restrict in any way the rights of the Corporation or the Optionee, which rights
are hereby expressly reserved by each, to terminate Optionee's Service at any
time for any reason whatsoever, with or without cause.

                                        SYNBIOTICS CORPORATION


                                        By:
                                           -------------------------------------
                                        Title:
                                              ----------------------------------

                                        ----------------------------------------
                                        OPTIONEE

                                        Address:
 
                                        ----------------------------------------
                                        ----------------------------------------

Dated: _________________, 199__

                                      -2-
<PAGE>
 
                                   EXHIBIT A

                             SYNBIOTICS CORPORATION
                             STOCK OPTION AGREEMENT
                             ----------------------


A.   Synbiotics Corporation (the "Corporation") has adopted the 1996 Stock
     Option Plan (the "Plan") for the purpose of attracting and retaining the
     services of selected persons who contribute to the financial success of the
     Corporation or its Parents or Subsidiaries.

B.   Optionee is an individual who is to render valuable services to the
     Corporation or its Parents or Subsidiaries, and this Agreement is executed
     pursuant to, and is intended to carry out the purposes of, the Plan in
     connection with the Corporation's grant of a stock option to Optionee.

NOW, THEREFORE, it is hereby agreed as follows:

1.   GRANT OF OPTION.  Subject to and upon the terms and conditions set forth in
     ---------------                                                            
     this Agreement, the Corporation hereby grants to Optionee, as of the grant
     date (the "Grant Date") specified in the accompanying Notice of Grant of
     Stock Option (the "Notice of Grant"), a non-qualified stock option to
     purchase up to that number of shares of the Corporation's Common Stock (the
     "Option Shares") as is specified in the Notice of Grant.  The Option Shares
     shall be purchasable from time to time during the option term at the option
     price per share (the "Option Price") specified in the Notice of Grant.

2.   OPTION TERM.  This option shall have a maximum term of ten (10) years
     -----------                                                          
     measured from the Grant Date and shall accordingly expire at the close of
     business on the expiration date (the "Expiration Date") specified in the
     Notice of Grant, unless sooner terminated in accordance with Paragraph 4 of
     this Agreement.

3.   EXERCISABILITY.  This option shall become exercisable for the Option Shares
     --------------                                                             
     in one or more installments as specified in the Notice of Grant.  As the
     option becomes exercisable for the Option Shares in one or more such
     installments, those installments shall accumulate and the option shall
     remain exercisable for the accumulated installments until the Expiration
     Date or the sooner termination of the option term under Paragraph 4 of this
     Agreement.

4.   TERMINATION OF SERVICE.  The option term specified in Paragraph 2 shall
     ----------------------                                                 
     terminate (and this option shall cease to be exercisable) prior to the
     Expiration Date should one of the following provisions become applicable:

     A.   Except that this option shall immediately terminate at the time of
          Optionee's termination for cause and except to the extent otherwise
          provided in subparagraphs (B) through (C) below, should Optionee cease
          to remain in the Service of the Corporation at any time during the
          option term, then this option shall not remain exercisable for more
          than a thirty (30)-day period commencing with the date of such
          cessation of Service. Upon the expiration of such thirty (30)-day
          period, this option shall terminate and cease to be outstanding.

     B.   Should Optionee die while in Service or within the thirty (30)-day
          period following his or her cessation of Service, then the personal
          representative of the Optionee's estate or the person or persons to
          whom this option is transferred pursuant to the Optionee's will or in
          accordance with the law of descent and distribution shall have the
          right to exercise this option.  Such right shall

                                      A-1
<PAGE>
 
          lapse, and this option shall terminate and cease to remain
          exercisable, upon the expiration of the twelve (12)-month period
          measured from the date of Optionee's death.

     C.   Should Optionee become permanently disabled (as defined in Internal
          Revenue Code Section 22(e)(3)) and cease by reason thereof to remain
          in Service at any time during the option term, then this option shall
          not remain exercisable for more than a twelve (12) month period
          commencing with the date of such cessation of Service.  Upon the
          expiration of such limited period of exercisability, this option shall
          terminate and cease to be outstanding.

     D.   Should a Corporate Transaction be consummated and this option not be
          assumed by the successor corporation (or parent thereof), this option
          shall immediately terminate and cease to be exercisable.

     E.   Notwithstanding subparagraphs (A) through (C) above, in no event shall
          this option be exercisable at any time after the Expiration Date or,
          if earlier, the time specified in subparagraph (D).

     F.   During the limited post-Service period of exercisability determined in
          accordance with subparagraphs (A) through (C) above, this option may
          not be exercised for more than the number of Option Shares (if any)
          for which this option is, at the time of the Optionee's cessation of
          Service, exercisable.

5.   ADJUSTMENT IN OPTION SHARES.  In the event any change is made to the Common
     ---------------------------                                                
     Stock issuable under the Plan by reason of any stock split, stock dividend,
     recapitalization, combination of shares, exchange of shares, or other
     change affecting the outstanding Common Stock as a class without the
     Corporation's receipt of consideration, then appropriate adjustments shall
     be made to (i) the total number of Option Shares subject to this option,
     (ii) the number of Option Shares for which this option is to be exercisable
     from and after each installment date specified in the Notice of Grant, and
     (iii) the Option Price payable per share in order to reflect such change
     and thereby preclude a dilution or enlargement of benefits hereunder.

6.   MANNER OF EXERCISING OPTION.
     --------------------------- 

     A.   In order to exercise this option with respect to all or any part of
          the Option Shares for which this option is at the time exercisable,
          Optionee (or in the case of exercise after Optionee's death, the
          Optionee's executor, administrator, heir or legatee, as the case may
          be) must take the following actions:

          (i)    Execute and deliver to the Secretary of the Corporation (a) a
                 written notice of exercise (the "Exercise Notice"), in
                 substantially the form of Exhibit I attached hereto, in which
                                           ---------                          
                 there is specified the number of Option Shares for which the
                 option is exercised.

          (ii)   Pay the aggregate Option Price for the purchased shares in one
                 or more of the alternative forms specified in Article Two,
                 Section I.A.2 of the Plan.

          (iii)  Furnish to the Corporation appropriate documentation that the
                 person or persons exercising the option (if other than the
                 Optionee) have the right to exercise this option.

          (iv)   Make appropriate arrangements with the Corporation (or the
                 Parent or Subsidiary employing or retaining Optionee) for the
                 satisfaction of any Federal, State or local income tax
                 withholding requirements and Federal social security employee
                 tax requirements applicable to the exercise of this option.

                                      A-2
<PAGE>
 
     B.  As soon after the Exercise Date as practical, the Corporation shall
mail or deliver to or on behalf of the Optionee (or to any other person or
persons exercising this option) a certificate or certificates representing the
purchased shares.

     C.   In no event may this option be exercised for any fractional shares.

7.   COMPLIANCE WITH LAWS AND REGULATIONS.
     ------------------------------------ 

     A.   The exercise of this option and the issuance of the Option Shares upon
          such exercise shall be subject to compliance by the Corporation and
          the Optionee with all applicable requirements of law relating thereto
          and with all applicable regulations of any stock exchange or national
          market system on which shares of the Option Shares may be listed at
          the time of such exercise and issuance.

     B.   In connection with the exercise of this option, Optionee shall execute
          and deliver to the Corporation such representations in writing as may
          be requested by the Corporation in order for it to comply with the
          applicable requirements of federal and state securities laws.

8.   SUCCESSORS AND ASSIGNS.  The provisions of this Agreement shall inure to
     ----------------------                                                  
     the benefit of, and be binding upon, the successors, administrators, heirs,
     legal representatives and assigns of Optionee and the successors and
     assigns of the Corporation.  Notwithstanding the foregoing, the Corporation
     need not honor any transfer of this option unless there is delivered to the
     Corporation a duly executed written instrument of transfer in form
     satisfactory to the Corporation.

9.   LIABILITY OF CORPORATION.  The inability of the Corporation to obtain
     ------------------------                                             
     approval from any regulatory body having authority deemed by the
     Corporation to be necessary to the lawful issuance and sale of any Common
     Stock pursuant to this option shall relieve the Corporation of any
     liability with respect to the non-issuance or sale of the Option Shares as
     to which such approval shall not have been obtained.  The Corporation,
     however, shall use its best efforts to obtain all such approvals.

10.  NOTICES.  Any notice required to be given or delivered to the Corporation
     -------                                                                  
     under the terms of this Agreement shall be in writing and addressed to the
     Corporation in care of the Corporate Secretary at the Corporation's
     principal corporate offices.  Any notice required to be given or delivered
     to Optionee shall be in writing and addressed to Optionee at the address
     indicated below Optionee's signature line on the Notice of Grant.  Either
     party may change its address for notice by giving written notice of such
     change.  All notices shall be deemed to have been given or delivered upon
     personal delivery or upon deposit in the U.S. mail, postage prepaid and
     properly addressed to the party to be notified.

11.  CONSTRUCTION.  This Agreement and the option evidenced hereby are made and
     ------------                                                              
     granted pursuant to the Plan and are in all respects limited by and subject
     to the express terms and provisions of the Plan.  All decisions of the Plan
     Administrator with respect to any question or issue arising under the Plan
     or this Agreement shall be conclusive and binding on all persons having an
     interest in this option.  Capitalized terms not otherwise defined in this
     Agreement shall have the meanings assigned to such terms in the Plan,
     unless the context clearly requires otherwise.

12.  GOVERNING LAW.  The interpretation, performance, and enforcement of this
     -------------                                                           
     Agreement shall be governed by the laws of the State of California without
     resort to that State's conflict-of-laws rules.

                                      A-3
<PAGE>
 
13.  NO EMPLOYMENT OR SERVICE CONTRACT.  Nothing in this Agreement or in the
     ---------------------------------                                      
     Plan shall confer upon the Optionee any right to continue in the Service of
     the Corporation (or any Parent or Subsidiary employing or retaining
     Optionee) for any period of specific duration or interfere with or
     otherwise restrict in any way the rights of the Corporation (or any Parent
     or Subsidiary employing or retaining Optionee) or the Optionee, which
     rights are hereby expressly reserved by each, to terminate the Optionee's
     Service at any time for any reason whatsoever, with or without cause.


                                     A-4
<PAGE>
 
                                   EXHIBIT I
                                   ---------

                       NOTICE OF EXERCISE OF STOCK OPTION
                       ----------------------------------


I hereby notify Synbiotics Corporation (the "Corporation") that I elect to
purchase _________ shares of the Corporation's Common Stock (the "Purchased
Shares") pursuant to that certain option (the "Option") granted to me under the
Corporation's 1996 Stock Option Plan (the "Plan") on ________________, 199_ to
purchase up to __________ shares of such Common Stock at an option price of
$_________ per share (the "Option Price").

Concurrently with the delivery of this Exercise Notice to the Secretary of the
Corporation, I shall pay to the Corporation the Option Price for the Purchased
Shares in accordance with the provisions of my agreement with the Corporation
evidencing the Option and shall deliver whatever additional documents may be
required by such agreement as a condition for exercise.


- -----------------                   --------------------------------------------
Date                                Optionee


                    Address:
                                    --------------------------------------------
 
                                    --------------------------------------------

Print name in exact manner
it is to appear on the
stock certificate:
                                    --------------------------------------------
 
                                    --------------------------------------------

Address to which certificate
is to be sent, if different
from address above:
                                    --------------------------------------------

                                    --------------------------------------------

Social Security Number:
                       ----------------------------------

                                     A-I-1
<PAGE>
 
                                   EXHIBIT B
                                   ---------


 Reference is made to Exhibit 99.1 of this Registration Statement on Form S-8.

                                      B-1


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission